U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to<a class="excerpt-read-more" href=" More ...
The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for ...
The US Food and Drug Administration approves Novo Nordisk's weight-loss pill, giving the Danish drugmaker a leg up in the ...
Novo Nordisk (NVO) “announced that the FDA has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback